Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02593604
Other study ID # 14-015
Secondary ID U1111-1176-0162
Status Completed
Phase N/A
First received April 11, 2015
Last updated October 11, 2017
Start date March 15, 2015
Est. completion date April 15, 2017

Study information

Verified date October 2017
Source University of Schleswig-Holstein
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Patients undergoing wide surgical excision of their hidradenitis suppurativa areas are asked by telephone about their quality of life by standard questionnaires (WHOQOL-BREF, DLQI, Skindex, MHF, FLQA-d) and their sexual function (FSFI, IIEF).


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date April 15, 2017
Est. primary completion date April 15, 2017
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Hidradenitis suppurativa that was wide excised in 2013 in Fachklinik Hornheide

- Agreed to retrospective analysis and questionnaires

Exclusion Criteria:

- Non-compliance

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Germany University of Schleswig-Holstein Lübeck Schleswig-Holstein

Sponsors (2)

Lead Sponsor Collaborator
University of Schleswig-Holstein Fachklinik Hornheide an der Universität Münster

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quality of Life (WHOQOL-BREF) Quality of Life is checked by WHOQOL-BREF 2 years postop
Primary Quality of Life (DLQI) Quality of Life is checked by DLQI 2 years postop
Primary Quality of Life (FLQA-d) Quality of Life is checked by FLQA-d 2 years postop
Primary Quality of Life (Skindex) Quality of Life is checked by Skindex 2 years postop
Secondary Sexual Function Sexual Function is checked by IIEF (male) and FSFI (female) 2 years postop
Secondary Demographic Parameters Patients' history 2 years postop
Secondary Smoking Smoking 2 years postop
Secondary Weight and height Weight and height 2 years postop
Secondary Wound assessment Localization, Hurley Stage, pain before operation 2 years postop
See also
  Status Clinical Trial Phase
Completed NCT02904902 - Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa Phase 3
Completed NCT03628924 - A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS) Phase 2
Not yet recruiting NCT05531747 - Replicative Stress in Hair Follicle Stem Cells and Pathogeny of Hidradenitis Suppurativa N/A
Recruiting NCT06028230 - A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Phase 2
Completed NCT03275870 - Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa Phase 1/Phase 2
Completed NCT03248531 - A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa. Phase 2
Withdrawn NCT04100083 - Spironolactone for Hidradenitis Suppurativa Phase 4
Completed NCT00329823 - Etanercept in Hidradenitis Suppurativa Phase 2
Recruiting NCT05710393 - Hidradenitis - an Analysis of Genetic Traits and Linkages in Families
Completed NCT04019041 - A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa Phase 2
Completed NCT05286567 - A Double-blind Placebo-controlled Randomized Trial Evaluating the Efficacy and Safety of a Novel HSP90 Inhibitor (RGRN-305) in the Treatment of Moderate to Severe Hidradenitis Supppurativa. Phase 1
Withdrawn NCT03929835 - Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa Phase 2
Terminated NCT04325607 - Negative Pressure Wound Therapy With Instillation for Treatment of Hidradenitis Suppurativa N/A
Terminated NCT03238469 - Microwave Ablation in Mild Axillary Hidradenitis Suppurativa N/A
Completed NCT04449354 - HidraWear AX HS Study N/A
Recruiting NCT06123429 - Mindfulness in Hidradenitis Suppurativa N/A
Recruiting NCT05934825 - Clinical Trial to Evaluate Safety and Efficiency of Mesenchymal Stem Cell in Patients With Hidradenitis Suppurativa Phase 1/Phase 2
Recruiting NCT05635266 - A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Recruiting NCT06046729 - A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Phase 2
Recruiting NCT04246372 - Tofacitinib for Immune Skin Conditions in Down Syndrome Phase 2